Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain.

Trial Profile

Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2013 Quality of life results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
    • 04 Jun 2013 Primary endpoint of Cognitive Composite score has not been met, according to results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
    • 04 Jun 2013 Cognitive function results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top